Please do not leave this page until complete. This can take a few moments.
Bio-Med Devices Inc. has been shaping the future of respiratory care for over 50 years, but its story is more than a timeline – it’s a legacy built on family, risk and deep-rooted purpose.
The company began in 1973 as a small business with big ambitions. A couple of years later, Dean Bennett Jr. took out a second mortgage on his home to buy the company, believing wholeheartedly in its potential. Alongside his wife, Doris Bennett, and their son, Dean Bennett III, he laid the foundation for what would become a respected name in medical technology – both nationally and internationally.
From the beginning, Bio-Med Devices focused on developing respiratory equipment to support the most vulnerable patients – premature infants in neonatal intensive care units. The company’s early innovations combined precision with user-friendliness, a combination that quickly earned the trust of clinicians across the country. These were life-saving tools designed to be intuitive in high-pressure environments, and their impact was immediate.
In the decades that followed, Bio-Med Devices expanded its portfolio by adding new ventilator lines and air-oxygen blenders designed to support patients of all ages. The key to growth was listening – really listening – to the people using its products every day. Feedback from healthcare professionals pushed Bio-Med Devices to refine its designs for safety, simplicity and performance. That close collaboration with clinicians remains central to the company’s approach today.
Bio-Med Devices is now known worldwide for producing reliable, high-quality respiratory care equipment. Its technology is used in hospitals, NICUs, and emergency response units across the globe, and the company is proud to support medical professionals who depend on its devices.
Equally important, Bio-Med Devices is one of the only ventilator manufacturers that still designs, builds and tests equipment entirely on American soil – something the company believes directly contributes to quality, reliability and responsiveness.
A defining moment for Bio-Med Devices came during the Covid-19 pandemic. As hospitals faced an unprecedented surge in ventilator demand, the team in Guilford stepped up without hesitation. Employees worked day and night, often seven days a week, to produce ventilators and air-oxygen blenders needed across the country. Their hard work and dedication helped save lives. Connecticut Gov. Ned Lamont contracted with Bio-Med Devices to support the state’s pandemic response – recognition that reflected not just the company’s technical capabilities, but its commitment to doing the right thing in a time of crisis.
Today, Bio-Med Devices employs around 80 individuals dedicated to the mission of improving patient outcomes through innovation. Continuing the family legacy, Dean Bennett IV joined the company in 2019, representing the third generation of leadership committed to advancing life-saving technology.
But beyond the technology, what defines the company is pride. Team members do not just manufacture medical devices – they build life-saving tools that families and healthcare workers rely on. Everyone from the engineers to the assemblers understands the weight of that responsibility. It drives their quality and fuels their purpose.
“I have always felt privileged to work in an industry that makes a difference, a real positive impact on peoples’ lives. To have been able to do that in 2020 and 2021, when so many people were isolated and afraid, to continue to go to work knowing the products we were building and developing were helping to save lives, was fulfilling beyond words. Bio-Med Devices is a family-owned business that has continued to innovate and grow for more than fifty years, a remarkable achievement,” according to Raymond Huey, President.
Looking ahead, Bio-Med Devices remains committed to leading the next era of respiratory care. “We will continue to innovate, adapt and collaborate – never losing sight of the values that started it all in 1973: family, determination and the belief that saving lives is the greatest work there is,” said company CEO Dean Bennett III.
ADDRESS: 61 SOUNDVIEW ROAD, GUILFORD, CT 06437
PHONE: ( 203) 458- 0202
WEBSITE: BIOMEDDEVICES.COM
TOP EXECUTIVE:DEAN BENNETT III, CEO
PRODUCT OR SERVICE: MEDICAL VENTILATORS AND
OXYGEN BLENDERS
NO. OF EMPLOYEES: 80
YEAR FOUNDED: 1973
The Hartford Business Journal 2025 Charity Event Guide is the annual resource publication highlighting the top charity events in 2025.
Learn moreHartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
SubscribeDelivering vital marketplace content and context to senior decision-makers throughout Connecticut ...
All Year Long!
The Hartford Business Journal 2025 Charity Event Guide is the annual resource publication highlighting the top charity events in 2025.
Hartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
Delivering vital marketplace content and context to senior decision-makers throughout Connecticut ...
All Year Long!
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy